Collaborate Disseminate
Following a successful pilot study encompassing nearly one million children, the World Health Organization (WHO) is now recommending widespread use of the world’s first malaria vaccine across all sub-Saharan Africa. It is hoped the landmark vaccine can… Continue reading WHO announces “historic” roll-out of first malaria vaccine in Africa
A small but robust study from researchers at Australia’s Edith Cowan University has discovered one way exercise can help suppress cancer growth. The study found exercise induces muscles to release a type of protein that can slow the growth of tumor cel… Continue reading Significant discovery shows how exercise can directly slow cancer growth
A new study is describing a potential biomarker to identify a person’s risk of developing anorexia nervosa. The research proposes measuring levels of anxiety alongside a specific type of twitching eye movement can effectively identify both those with, … Continue reading Twitching eye movement could offer objective anorexia diagnosis
New Australian research is systematically investigating the anticonvulsant effects of a number of rare compounds in cannabis. A new study is reporting cannabigerolic acid (CBGA), informally known as the “mother of all cannabinoids,” may be more effecti… Continue reading CBGA, the “mother of all cannabinoids”, reduces seizures more effectively than CBD
Researchers from the University of Toledo have discovered a prospective new treatment for rheumatoid arthritis. The vaccine-based treatment strategy proved successful in preliminary animal studies and the researchers are looking to conduct more clinica… Continue reading Scientists stumble on rheumatoid arthritis vaccine with huge potential
The European Medicines Agency (EMA) has issued a broad approval for all adults over the age of 18 to be allowed a third Pfizer COVID-19 vaccine dose at least six months after a second dose. The regulator’s advice follows on from recent similar booster … Continue reading European regulator backs Pfizer COVID-19 vaccine booster for all adults
An incredible proof-of-concept study has demonstrated how a brain implant can treat severe depression by electrically stimulating certain brain regions. The cutting-edge experimental implant monitors neural activity for biomarkers signaling the onset o… Continue reading Experimental brain implant zaps away depression in real-time
Intriguing new preclinical research from a team of Japanese scientists has found targeting opioid receptors in the gut could be a new treatment for inflammatory bowel disease. The research builds on early evidence showing a relationship between opioids… Continue reading New discovery reveals direct link between opioids and gut inflammation
Pharmaceutical company Merck has revealed the first data from its large Phase 3 trial of an oral antiviral treatment for COVID-19. The interim results show the treatment reduces a person’s risk of hospitalization or death from COVID-19 by 50 percent wh… Continue reading First COVID-19 pill passes human trials, looks to FDA approval
Researchers from The Mount Sinai Hospital have found changes to electrical activity in the heart can help predict which hospitalized COVID-19 patients are more likely to decline and die. The biomarker is easily measurable and potentially predicts death… Continue reading Newly discovered biomarker predicts COVID-19 death days in advance